Gustavo Oderich(@GustavoOderich) 's Twitter Profileg
Gustavo Oderich

@GustavoOderich

Proud Dad, Sailor, Fitness advocate/ Professor of Surgery & Chief of Vascular Surgery/ Director of Aortic Center, @UTH_CVSurgery at @McGovernMed & @UTHealth

ID:3187165626

linkhttps://med.uth.edu/cvs/faculty/gustavo-s-oderich-md-facs/ calendar_today07-05-2015 02:48:31

141 Tweets

2,8K Followers

3,6K Following

Gustavo Oderich(@GustavoOderich) 's Twitter Profile Photo

First fenestrated repair using Cook Medical 4-vessel ZFEN+ fenestrated device at UTHealth Houston. Congratulations to all the team members for playing their essential part. A huge step forward towards individualized surgery: fitting device to patient, not patient to device!

First fenestrated repair using @CookMedical 4-vessel ZFEN+ fenestrated device at @UTHealthHouston. Congratulations to all the team members for playing their essential part. A huge step forward towards individualized surgery: fitting device to patient, not patient to device!
account_circle
Cook Medical(@CookMedical) 's Twitter Profile Photo

NEWS: The first patient has been treated in the clinical study of Cook Medical’s ZENITH® FENESTRATED+ Endovascular Graft (ZFEN+) in the United States. Read the details: bit.ly/48285tY

NEWS: The first patient has been treated in the clinical study of Cook Medical’s ZENITH® FENESTRATED+ Endovascular Graft (ZFEN+) in the United States. Read the details: bit.ly/48285tY
account_circle
Gustavo Oderich(@GustavoOderich) 's Twitter Profile Photo

The Cook ZFEN+ IDE is approved by the FDA to start trial. Finally a tailored, patient specific fenestrated stent-graft to repair complex aortic aneurysms with more sealing, less compromise on vessel incorporation. It will expand indications of EVAR significantly!

The Cook ZFEN+ IDE is approved by the FDA to start trial. Finally a tailored, patient specific fenestrated stent-graft to repair complex aortic aneurysms with more sealing, less compromise on vessel incorporation. It will expand indications of EVAR significantly!
account_circle
Gustavo Oderich(@GustavoOderich) 's Twitter Profile Photo

Congratulations to Dr. Enrico Ascher for receiving the SVS Lifetime Achievement Award, the highest honor of our specialty. As a Brazilian vascular surgeon, this is a special and inspiring moment for all of us. Vascular SVS Think Aorta US AortaEd VEITHsymposium

Congratulations to Dr. Enrico Ascher for receiving the SVS Lifetime Achievement Award, the highest honor of our specialty. As a Brazilian vascular surgeon, this is a special and inspiring moment for all of us. @VascularSVS @ThinkAortaUS @AortaEd @VEITHsymposium
account_circle
Gustavo Oderich(@GustavoOderich) 's Twitter Profile Photo

5-year patient survival after Extent I-III is ~50%, similar to survival and less than population. 9 out 10 patients die from non aortic causes. What’s next: more compliant stents? Better medical therapy? We need to stop focus more on survival not stent outcomes

5-year patient survival after Extent I-III #fbevar #taaa is ~50%, similar to #CHF survival and less than population. 9 out 10 patients die from non aortic causes. What’s next: more compliant stents? Better medical therapy? We need to stop focus more on survival not stent outcomes
account_circle
Gustavo Oderich(@GustavoOderich) 's Twitter Profile Photo

Congrats Andrea. Fresh J Vascular Surgery failed . Low mortality. Effective but one major negative: more type 2 endoleak and higher rates of sac enlargement!

Congrats Andrea. Fresh @JVascSurg #fbevar failed #evar. Low mortality. Effective but one major negative: more type 2 endoleak and higher rates of sac enlargement!
account_circle
Collin Rugg(@CollinRugg) 's Twitter Profile Photo

THROWBACK: Biden calls the *true* Hunter Biden laptop story ‘Russian disinformation,’ ‘a smear campaign,’ and ‘a bunch of garbage.’

Turns out his presidential campaign colluded with the CIA to win an election.

Yes, you read that correctly: The Biden campaign pressured the then…

account_circle
Gustavo Oderich(@GustavoOderich) 's Twitter Profile Photo

Fresh from in Toronto in 2,603 patients with mortality of 4.5% for elective and 17% for non-elective procedures. Risk of aortic death 9% in 5yrs. Next steps: how to reduce reintervention and cost?

Fresh from #asa23 in Toronto #FBEVAR in 2,603 #TAAA patients with mortality of 4.5% for elective and 17% for non-elective procedures. Risk of aortic death 9% in 5yrs. Next steps: how to reduce reintervention and cost?
account_circle
Gustavo Oderich(@GustavoOderich) 's Twitter Profile Photo

Honored to be new member @ Texas Surgical Society. Thank you for ‘James E. Thompson Award’ for best paper! Grateful to maintain excellence in 573 consecutive UTHealth Houston and Mayo Clinic despite more extensive anatomy and sicker patients. Overall mortality of 1%

Honored to be new member @ Texas Surgical Society. Thank you for ‘James E. Thompson Award’ for best paper! Grateful to maintain excellence in 573 consecutive #fbevar #taaa @UTHealthHouston and @MayoClinic despite more extensive anatomy and sicker patients. Overall mortality of 1%
account_circle
Karen Woo MD PhD FACS(@KarenWooMD) 's Twitter Profile Photo

The first scientific presentation of the 50th Annual SCVS Symposium is also the winner of the Peter B Samuels best paper award. 🎉🎉🎉🙌💪👊
Gustavo Oderich

The first scientific presentation of the 50th Annual @SCVS1969 Symposium is also the winner of the Peter B Samuels best paper award. 🎉🎉🎉🙌💪👊 @GustavoOderich
account_circle
Gustavo Oderich(@GustavoOderich) 's Twitter Profile Photo

Congrats to Guilherme Baumgardt for shining evidence that can be done without the traditional bare metal stent. Identical results with or without simone cristina Gustavo Oderich

Congrats to Guilherme Baumgardt for shining evidence that #fevar can be done without the traditional bare metal stent. Identical results with or without @scvs #scvs2023 @GustavoOderich
account_circle